LogicBio Therapeutics COO Sandra Poole receives $2.1M in 2018
LogicBio Therapeutics reports 2018 executive compensation
By ExecPay News
Published: April 29, 2019
LogicBio Therapeutics reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, three executives at LogicBio Therapeutics received on average a compensation package of $1.8M, a 127% increase compared to previous year.
Average pay of disclosed executives at LogicBio Therapeutics
Sandra Poole, Chief Operating Officer, received $2.1M in total. 85% of Poole's compensation, or $1.8M, was in option awards. Poole also received $68K in bonus, $244K in salary, as well as $4.9K in other compensation.
Frederic Chereau, Chief Executive Officer, received a compensation package of $1.6M, which increased by 105% compared to previous year. 63% of the compensation package, or $1M, was in option awards.
Dean Falb, Chief Scientific Officer, earned $1.6M in 2018.
Related executives
You may also like
Source: SEC filing on April 29, 2019.